Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis.
Fingolimod Increases CD39-Expressing Regulatory T Cells in Multiple Sclerosis Patients.
Cognitive impairment in multiple sclerosis: clinical, radiologic and pathologic insights.
Robust Perfusion Deficits in Cognitively Impaired Patients with Secondary-Progressive Multiple Sclerosis.
Multiple sclerosis: Risk factors for progressive multifocal leukoencephalopathy identified in natalizumab-treated patients.
Neuroplasticity and functional recovery in multiple sclerosis.
Cystoid macular oedema after fingolimod treatment in multiple sclerosis.
Fatigue in multiple sclerosis: relationship with disease duration, physical disability, disease pattern, age and sex.
Complete bilateral horizontal internuclear ophthalmoplegia as a sign of multiple sclerosis relapse.
[2011: What's new in dysimmune neuropathies.]
2-photon imaging of phagocyte-mediated T cell activation in the CNS.
Idiopathic inflammatory demyelinating diseases of the central nervous system in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors and survival.
JC virus Reactivation During Prolonged Natalizumab Monotherapy for Multiple Sclerosis.
Self-tolerance in multiple sclerosis.
Imaging of microglia in patients with neurodegenerative disorders.
The role of the immune system in the generation of neuropathic pain.
Cooperative roles of NF-κB and NFAT4 in polyomavirus JC regulation at the KB control element.
Altered collagen expression in jugular veins in multiple sclerosis.
[The role of dopamine in the regulation of the interaction between nervous and immune systems in multiple sclerosis.]
Pulmonary Hypertension and Multiple Sclerosis - Coincidence or Association?
Simvastatin improves final visual outcome in acute optic neuritis: a randomized study.
Sexual disorders in men with multiple sclerosis: Evaluation and management.
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
Spatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5).
Acquired perforating dermatosis associated with natalizumab.

Pages